Neurizon Therapeutics Limited

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.neurizon.com

Country

Australia

Exchange

ASX

Neurizon Therapeutics Limited, a clinical stage biotechnology company develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases.

Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis to treat other neurodegenerative diseases.

Formerly known as PharmAust Limited, the company rebranded as Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.

Key Stats

52-Week Range

A$0.06A$0.17

Beta1.31

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.03

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceA$0.20

RecommendationStrong Buy

Recommendation Mean1.00

Recent SEC Filings

SEC filings for this ticker are not available yet.